XX2KXDBMonitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11

ICD-10-PCS XX2KXDB
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XX2KXDB is a billable ICD-10-PCS procedure code for Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Monitoring involves determining the level of a physiological or physical function repetitively over a period of time.

Code Identity

ICD-10-PCS Code
XX2KXDB
Billable Status
Yes — Valid for Submission
Code Describes
Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11
Parent Code
XX2 New Technology, Physiological Systems, Monitoring
Short Description
Monitor Interstitl Glucose, Werabl Sensor Extern New Tech 1

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemXPhysiological Systems
3Operation2Monitoring
4BodyPartKSubcutaneous Tissue
5ApproachXExternal
6Device/Substance/TechnologyDInterstitial Glucose, Wearable Sensor
7QualifierBNew Technology Group 11

Code History

FY 2026New code, effective October 1, 2025.

Similar Procedure Codes

Questions About XX2KXDB

Is XX2KXDB a billable code?

Yes. XX2KXDB is a complete seven-character ICD-10-PCS code, specific enough to report Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XX2KXDB mean?

XX2KXDB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character 2 is the Operation (Monitoring); the 4th character K is the BodyPart (Subcutaneous Tissue); the 5th character X is the Approach (External); the 6th character D is the Device/Substance/Technology (Interstitial Glucose, Wearable Sensor); the 7th character B is the Qualifier (New Technology Group 11).